The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 85 | — | 20.1x | Above average | |
Growth | 5 | -42.0% | 5.6% | Below average | |
Quality | 17 | -120.0% | 7.6% | Below average | |
Safety | 58 | 0.3x | 0.4x | Near average | |
Capital Return | 61 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
DocGo Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy DocGo Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
DocGo stock shows a state of extreme uncertainty as the number of analysts covering the stock has dropped from 4 to only 1 in recent updates, making the average price target ($5.84) unrepresentative of a true market consensus at this time. Although the remaining price target significantly exceeds the current price ($0.6272), the wide gap between the high ($11) and low ($1.5) estimates reflects sharp dispersion in fair value assessments.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.